探析慢阻肺全流程管理在慢阻肺患者病程中的作用

Abstract: Objective chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, affecting one-tenth of the global population. It has been identified by the World Health Rrganization (WHO) as a major unmet global health need and has become a global public health issue. However, the role of full-process management in COPD remains unclear. Therefore, this study intends to explore the impact of full-process management on patients with COPD. Methods A total of 128 outpatients or inpatients diagnosed with COPD in our hospital from January 2024 to December 2024 were selected as the research objects and divided into two groups by random number table method, with 64 patients in each group. Through pulmonary function tests, chronic obstructive pulmonary disease assessment test (CAT), and changes in the forced expiratory volume in 1 second (FEV1) levels, the role of the full-process management in the management of COPD patients was analyzed. Results Among the 128 patients, 121 completed the study, with a completion rate of 94.5%. Before the start of the study, all indicators were analyzed based on the random grouping. There was no statistically significant difference in the baseline data between the two groups, which met the requirements of the study. At the end of the study, the FEV1 (89.55%±0.26%), Borg dyspnea score (4.55±0.26), and CAT score (16.94±5.34) of the full-process management group were significantly better than those of the routine management group, which were FEV1 (81.11%±1.25%), Borg dyspnea score (6.11±0.25), and CAT score (19.49±5.92), respectively. The differences were statistically significant. Conclusion Full-process management for COPD patients helps alleviate lung function damage and plays a positive role in patients’ recovery or maintenance of physical condition.